期刊文献+

国家药品抽检样品受理问题分析及建议 被引量:3

Analysis and Suggestions on the Registration of National Drug Sampling Inspection
下载PDF
导出
摘要 目的:为提高国家药品抽检样品受理的效率提出相应建议。方法:根据2018年度国家药品抽检工作在样品接收和受理登记环节中遇到的问题,分析问题产生的原因,从而提出解决问题的办法。结果与结论:建议各抽样机构认真解读《国家药品抽检工作手册》,严格执行国家药品抽检实施方案的抽样要求;抽样人员按照方案中的抽样数量抽取样品,按样品说明书要求的储藏条件保存和寄运;受理登记人员在受理审核环节严格把关,确保样品信息的准确无误。 Objective:To put forward some suggestions to improve the registration efficiency of national drug sampling inspection.Methods:To summarize the problems encountered in the process of sample receiving and registration of national drug sampling inspection of NIFDC in 2018,analyze the causes of the problems,and then propose solutions to the problems.Results and Conclusion:It is suggested that all sampling institutions should seriously interpret the national drug sampling inspection manual and strictly implement the detailed contents in the sampling requirements of the national drug sampling inspection implementation plan.Sampling personnel should take samples according to the sample quantity in the plan,and the samples should be transported by post according to their storage and transportation conditions specified in the sampling instructions;Registration personnel should check strictly to ensure that the sample information is accurate.
作者 高芳 梁静 杨玥莹 王敬 董红环 黄清泉 Gao Fang;Liang Jing;Yang Yueying;Wang Jing;Dong Honghuan;Huang Qingquan(National Institutes for Food and Drug Control,Beijing 102629,China)
出处 《中国药事》 CAS 2020年第6期632-635,共4页 Chinese Pharmaceutical Affairs
关键词 国家药品抽检 抽样 受理登记 national drug sampling inspection sampling registration
  • 相关文献

参考文献3

二级参考文献13

  • 1高轩.论行政法的基本原则[J].华中科技大学学报(社会科学版),2001,15(2):19-22. 被引量:3
  • 2郑策,梅丹,王兰,李大魁,汤光.关注制剂中辅料的不良反应[J].中国药学杂志,2005,40(9):644-649. 被引量:143
  • 3SFDA. Report for the reform of sampling test mode for drugs [R/OL]. 2006-03-20. http://www.315jj.com/article 106.aspx. 被引量:1
  • 4SFDA.The construction of the index system and the quality index for drugs in our country [N/OL]. 2011-04-05. http://wenku. baidu.com/view/965a63e8e009581 b6bd9eb 1 a.html?from=related. 被引量:1
  • 5WANG M. The role and significance of sampling test for drugs [J]. Strait Pharm J, 2007, 19(6): 133-134. 被引量:1
  • 6SFDA. State's Quality Notice of Drugs in 2008-2010 [R/OL]. 2011-01-19. http://www.s fda.gov.cn/WS01/CL0084. 被引量:1
  • 7SFDA. State's Annual Report of Drugs in 2008-2010 [R/OL]. 2011-11-02. http://www.sfda.gov.cn/WS01/CL0010. 被引量:1
  • 8Jiangsu FDA. Concealment and avoidance of quack medicine [N/OL] 2008-03-14. http: //www.xinhuanet.com/chinanews/ 2008-03/14/content 12704873.htm. 被引量:1
  • 9GUO Z X, HUANG Z L, ZHANG C. The usage of risk evaluation in sampling test for drugs [J]. Chin Pharm Aff, 2011, 25(7): 764-767. 被引量:1
  • 10中华人民共和国药品管理法[J]中国新药与临床杂志,2001(03). 被引量:1

共引文献36

同被引文献11

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部